All In MedTech

Device Trial Radar · NCT06698731

A Randomized, Active-Controlled, Double-Masked, Crossover Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens for Presbyopia Extended Depth of Focus (EDOF)

Last checked: Nov 20, 2026Latest source record: Mar 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

78

Actual

Start

Oct 28, 2024

Primary completion

Jan 13, 2025

Study completion Jan 15, 2025

Sponsor

Lead sponsor
Bruno Vision CareNot on our public-company list
Sponsor type
Industry
Collaborators
iuvo BioScience Operations, LLC
First posted
Nov 21, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 45 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if the contact lens we are testing will work to extend the range of clear focus at distance to provide an increase in clear vision at closer ranges without the additional need for bifocal lenses or reading correction. The clinical study will compare the use of the test lens for extended range of focus (far to near) to a standardized contact lens designed for distance vision (far) (ie. Walking, driving, etc., where closer-in vision is not anticipated to be helpful, particularly in a population of users in the age range of 45-70. We will also learn about the effectiveness of the lens to maintain good contrast in low illumination such as during evening and night-time periods. The main questions we aim to address in the study are: \*. Does the contact lens provide adequate vision at distances closer to the patient such as during reading or computer usage? \* Whether the contact lens in use introduces any visual disturbance or safety concern as compared to a currently designed lens for distance use? The study is designed to be conducted in the doctor's office: * Using electronic vision measuring equipment familiar to the user. * A total of two visits are necessary to complete he study * All patients will experience using the test lens as well as the control lens during the study * No contâct lenses will be given to the study patients to take home. * It is anticipated that the total amount of time of participation in the study will be approximately 3 hours of your time over two separate visits.

Conditions

  • Presbyopia Condition

Interventions

  • Test lensDevice

    The test lens is the Deseyne Daily Disposable soft contact lens

  • Control lensDevice

    The control lens is the 1-Day AcuVue Moist Daily Disposable single vision contact lens

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Primary Effectiveness Endpoint for the Study is Monocular (Study [Right] Eye Only) Photopic Negative Lens-induced Distance-corrected Depth of Focus (DOF) at the 0.2 logMAR VA Threshold.Time frame: Day 1

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Omega VisionCenter PA

    Longwood, Florida

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.